MAM
NVCR icon

Montanaro Asset Management’s NovoCure NVCR Stock Holding History

Montanaro Asset Management’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-21,800
Closed -$1.64M – 46
2021
Q4 		$1.64M Sell
21,800
-73,000
-77% -$7.33M 0.17% 42
2021
Q3 		$11M Sell
94,800
-21,850
-19% -$3.3M 1.33% 25
2021
Q2 		$25.9M Buy
116,650
+2,000
+2% +$389K 3.26% 13
2021
Q1 		$15.2M Sell
114,650
-24,950
-18% -$3.95M 2.23% 18
2020
Q4 		$24.2M Buy
+139,600
New +$19.1M 4.07% 11

Other funds holding NVCR

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Montanaro Asset Management's NVCR Position: Q1 2022 in Review

Montanaro Asset Management sold out of NovoCure (NVCR) in Q1 2022, closing a stake of 21,800 shares — an estimated $1.64M sold.

Montanaro Asset Management first reported a position in NVCR in Q4 2020 and held it in 5 quarters. The position peaked at $25.9M in Q2 2021. 308 funds tracked by Wall St. Rank hold NVCR as of Q1 2022.

  • Montanaro Asset Management reported no remaining NovoCure position as of Q1 2022 after selling out during the quarter.
  • Montanaro Asset Management sold 21,800 NovoCure shares in Q1 2022, an estimated $1.64M.
  • Montanaro Asset Management first reported a position in NovoCure in Q4 2020 and held it in 5 quarters.
  • Montanaro Asset Management's NovoCure position peaked at $25.9M in Q2 2021.
  • 308 funds tracked by Wall St. Rank held NovoCure as of Q1 2022.

Based on Montanaro Asset Management's 13F filing for Q1 2022, filed 12 May 2022.